Editorial introductions

Abstract

Current Opinion in Ophthalmology was launched in 1990. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Ophthalmology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Dean M. CestariDean M. CestariDr Cestari completed residencies in both Neurology and Ophthalmology at the Cornell University Medical College's New York Presbyterian Hospital, as well as fellowship training in neuro-ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School (HMS). He is one of approximately 10 physicians in the United States who is board certified by both the American Board of Ophthalmology and the American Board of Psychiatry & Neurology. Dr Cestari joined the full-time faculty of Mass. Eye and Ear, a primary teaching hospital for HMS, in 2006 and currently holds the rank of Assistant Professor of Ophthalmology, Harvard Medical School. He is very involved in medical education and is the Director of the Clinical Fellowship program at Mass. Eye and Ear. His efforts as a clinician-scientist focus on the evaluation and treatment of patients who present with neuro-ophthalmic disease. He is also very involved in the medical and surgical treatment of Thyroid Eye Disease with strabismus and diplopia. He just published a surgical textbook entitled, “Learning Strabismus Surgery, A Case Based Approach.” He supervises clinical fellows, second-year residents and visiting medical students and performs adult strabismus surgery and mentors second-year residents in the operating theater. Dr Cestari's translational research is focused on developing a rodent model for ischemic optic neuropathy and central retinal artery occlusion. Once this is accomplished, his team will begin to evaluate the safety and efficacy of various novel neuro-protective agents that can be used to preserve and restore vision affected by vascular occlusion. Additionally, he is working with a team of engineers from MIT and Harvard University to design and build an implantable device to restore ocular motility to denervated extra-ocular muscles from nerve palsys. Russell W. ReadRussell W. ReadDr Read graduated magna cum laude in 1994 from the University of Alabama School of Medicine in Birmingham (UAB), Alabama, USA. Dr Read completed a residency in ophthalmology at the University of Washington, Seattle, USA and dual fellowships at the Doheny Eye Institute, USA/University of Southern California, USA, in uveitis/ocular inflammatory diseases and ophthalmic pathology. Dr Read joined the faculty of the UAB Department of Ophthalmology in August 2000 where he is now Professor of Ophthalmology and Pathology. Dr Read is actively involved in the clinical care of patients with uveitis and ocular inflammatory diseases and serves as the Executive Secretary of the American Uveitis Society. He is the residency program Director for ophthalmology.